BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2106912)

  • 1. Relevance of class, molecular weight and isoelectric point in predicting human light chain amyloidogenicity.
    Bellotti V; Merlini G; Bucciarelli E; Perfetti V; Quaglini S; Ascari E
    Br J Haematol; 1990 Jan; 74(1):65-9. PubMed ID: 2106912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin light-chain immunoblots of urine proteins from patients with tubular and Bence-Jones proteinuria.
    Norden AG; Fulcher LM; Flynn FV
    Clin Chim Acta; 1987 Jul; 166(2-3):307-15. PubMed ID: 3113774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bence-Jones proteinuria and kidney's damages].
    Strada E; Battistelli L; Savazzi G
    Recenti Prog Med; 2008; 99(7-8):389-94. PubMed ID: 18751619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restricted electrophoretic heterogeneity of immunoglobulin light chains in urine: a cause for confusion with Bence Jones protein.
    MacNamara EM; Aguzzi F; Petrini C; Higginson J; Gasparro C; Bergami MR; Bianchi G; Whicher JT
    Clin Chem; 1991 Sep; 37(9):1570-4. PubMed ID: 1909942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary structure of the variable region of a human lambda VI light chain: Bence Jones protein SUT.
    Frangione B; Moloshok T; Solomon A
    J Immunol; 1983 Nov; 131(5):2490-3. PubMed ID: 6415173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of primary immunoglobulin light chain amyloidosis with a delayed appearance of Bence Jones protein in urine.
    Kurusu A; Yamada T; Yamaji K; Nishitani M; Tashiro K; Maeda K; Horikoshi S; Shirato I; Rinno H; Tomino Y
    Nephrology (Carlton); 2004 Jun; 9(3):122-5. PubMed ID: 15189172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bence Jones proteins and light chains of immunoglobulins. Preferential association of the V lambda VI subgroup of human light chains with amyloidosis AL (lambda).
    Solomon A; Frangione B; Franklin EC
    J Clin Invest; 1982 Aug; 70(2):453-60. PubMed ID: 6808027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and immunochemical studies of 20 patients with amyloidosis and plasma cell dyscrasia.
    Pick AI; Fröhlichmann R; Lavie G; Duczyminer M; Skvaril F
    Acta Haematol; 1981; 66(3):154-67. PubMed ID: 6795873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated amyloid lymphadenopathy.
    Naschitz JE; Yeshurun D; Kühnreich E; Pick AI; Boss J
    Acta Haematol; 1984; 72(4):274-7. PubMed ID: 6438995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The significance of analysis and detection of Bence Jones protein in the urine in clinical laboratory diagnosis].
    Végh Z; Ottó S
    Orv Hetil; 1989 Aug; 130(35):1871-5. PubMed ID: 2507996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical spectrum of light chain myeloma. A study of 35 patients with special reference to the occurrence of amyloidosis.
    Stone MJ; Frendel EP
    Am J Med; 1975 May; 58(5):601-19. PubMed ID: 1130419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteinuria in multiple myeloma and related diseases.
    Ganeval D; Lacour B; Chopin N; Grünfeld JP
    Am J Nephrol; 1990; 10 Suppl 1():58-62. PubMed ID: 2124083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic light-chain proteinuria: case report and review of the literature.
    Audard V; Damaj G; Rubio MT; Aucouturier P; Hermine O; Varet B
    Am J Hematol; 2004 Jul; 76(3):293-4. PubMed ID: 15224371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of serum free light chain analysis and urine protein electrophoresis for detection of monoclonal gammopathies.
    Holding S; Spradbery D; Hoole R; Wilmot R; Shields ML; Levoguer AM; Doré PC
    Clin Chem Lab Med; 2011 Jan; 49(1):83-8. PubMed ID: 20961192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete amino acid sequence determinations demonstrate identity of the urinary Bence Jones protein (BJP-DIA) and the amyloid fibril protein (AL-DIA) in a case of AL-amyloidosis.
    Klafki HW; Kratzin HD; Pick AI; Eckart K; Karas M; Hilschmann N
    Biochemistry; 1992 Mar; 31(12):3265-72. PubMed ID: 1554711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The urinary light-chain ladder pattern. A product of improved methodology that may complicate the recognition of Bence Jones proteinuria.
    Bailey EM; McDermott TJ; Bloch KJ
    Arch Pathol Lab Med; 1993 Jul; 117(7):707-10. PubMed ID: 8323434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benign Bence Jones gammopathy.
    Paladini G; Sala PG; Santini PA
    Acta Haematol; 1980; 63(5):241-6. PubMed ID: 6774550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoelectrophoretic investigations in 55 patients with systemic amyloidosis.
    Vital Durand D; Touraine JL; Levrat R; Zech P; Traeger J; Lejeune E; Creyssel R
    Blut; 1984 Aug; 49(2):91-4. PubMed ID: 6380625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephelometric assay of urine free light chains: an alternative and early clinical test for Bence-Jones protein quantification.
    Pieri M; Pignalosa S; Franceschini L; Rizzo M; Cantonetti M; Zenobi R; Bernardini S; Dessi M
    Clin Chem Lab Med; 2018 Nov; 56(12):e313-e315. PubMed ID: 29935112
    [No Abstract]   [Full Text] [Related]  

  • 20. Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence Jones cast nephropathy in a necropsy study of patients with myeloma.
    Iványi B
    Arch Pathol Lab Med; 1990 Sep; 114(9):986-7. PubMed ID: 2117910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.